STE Steris

company

SEC Filings & Insider Trading Activity 2026

Risk Factors

• • No new or updated risk factors reported since the fiscal 2025 10-K filed May 29, 2025
• • Continued risks from product liability and regulatory compliance remain material, including FDA regulations on medical devices
• • Ongoing market risk from competitive pressures in sterilization and healthcare sectors affecting near-term sales
• • Exposure to foreign currency fluctuations impacting reported earnings due to international operations
• • Debt refinancing risk due to upcoming maturities and variable interest rates described in 10-K

Management Discussion & Analysis

• • Revenue $1,496.2M Q3 FY2026, up 9.2% YoY from $1,370.6M; nine months revenue $4,347.5M, up 9.3% from $3,979.0M
• • Operating margin Q3 FY2026 18.2% ($273.2M/$1,496.2M) vs 17.9% YoY ($245.3M/$1,370.6M); nine months margin 18.1% vs 16.3% YoY
• • Best segment: AST segment Q3 revenues +11.0%, operating margin 45.1% vs 44.8% YoY; worst segment: Healthcare margin down to 24.3% vs 25.3% YoY
• • Operating cash flow $1,006.0M (+13.4% YoY), free cash flow $737.6M (+25.4% YoY); capital expenditures decreased to $278.8M from $299.2M
• • Management notes inflation, tariff costs pressure margins; expects benefit from restructuring; sales growth driven by volume and pricing; no updated guidance disclosed

What are the latest STE SEC filings in 2026?

Steris (STE) has filed a 10-K annual report on May 29, 2026, a 10-Q quarterly report on February 6, 2026, an 8-K current report on August 6, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did STE file its most recent 10-K annual report?

Steris (STE) filed its most recent 10-K annual report on May 29, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view STE 10-Q quarterly reports?

Steris (STE)'s most recent 10-Q quarterly report was filed on February 6, 2026. SignalX displays every STE 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has STE filed recently?

Steris (STE)'s most recent 8-K was filed on August 6, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find STE insider trading activity (Form 4)?

SignalX aggregates every STE Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does STE file with the SEC?

Steris (STE) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new STE filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Steris (STE).

What is STE's SEC CIK number?

Steris (STE)'s SEC CIK (Central Index Key) number is 1757898. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1757898 to look up all STE filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find STE return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Steris (STE) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.